Literature DB >> 9256332

Telomere length and telomerase activity in bladder and prostate cancer cell lines.

Y Kageyama1, S Kamata, J Yonese, H Oshima.   

Abstract

BACKGROUND: Specific repeats of oligonucleotides at the ends of chromosomes (telomeres) are shortened by cell division in somatic cells and are thought to be related to aging. Immortal cells such as germ-line cells or cancer cells have demonstrated increased activity of the telomere-elongating enzyme (telomerase). The length of the telomeres of these cells is stable regardless of cell division. We examined the telomere length and telomerase activity in 3 bladder (JTC30, JTC32, and T24) and 2 prostate cancer (LNCaP and DU145) cell lines.
METHODS: Telomere lengths were evaluated by Southern blot analysis with a oligonucleotide probe, (TTAGGG)5, and telomerase activities were detected with a polymerase chain reaction-based assay method.
RESULTS: Telomerase activity was detected in all of the cell lines. Each cell line had a specific telomere length. In 2 bladder cancer cell lines (JTC30 and JTC32), the telomere length decreased with increased passage of the cells.
CONCLUSION: The presence of telomerase may be a biological character of bladder and prostate cancers as well as other malignancies, although it does not always compensate telomere shortening.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256332     DOI: 10.1111/j.1442-2042.1997.tb00216.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  8 in total

Review 1.  Prostate cancer: the need for biomarkers and new therapeutic targets.

Authors:  Juliana Felgueiras; Joana Vieira Silva; Margarida Fardilha
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

2.  MYC and Prostate Cancer.

Authors:  Cheryl M Koh; Charles J Bieberich; Chi V Dang; William G Nelson; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  Genes Cancer       Date:  2010-06

Review 3.  Bladder tumor markers: need, nature and application. 1. Nucleus-based markers.

Authors:  M M Kirollos; S McDermott; R A Bradbrook
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

4.  Telomere attrition occurs during ex vivo expansion of human dental pulp stem cells.

Authors:  Jaroslav Mokry; Tomas Soukup; Stanislav Micuda; Jana Karbanova; Benjamin Visek; Eva Brcakova; Jakub Suchanek; Jan Bouchal; Doris Vokurkova; Romana Ivancakova
Journal:  J Biomed Biotechnol       Date:  2010-10-04

Review 5.  Telomeres and telomerase in endocrine pathology.

Authors:  G Kontogeorgos; K Kovacs
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

6.  Telomerase is upregulated in irreversible preneoplastic lesions during bladder carcinogenesis in rats.

Authors:  Toru Shimazui; Yoshihiro Ami; Naoto Miyanaga; Yukitaka Ideyama; Takahito Nakahara; Hideyuki Akaza
Journal:  Jpn J Cancer Res       Date:  2002-05

7.  High-throughput single-molecule telomere characterization.

Authors:  Jennifer McCaffrey; Eleanor Young; Katy Lassahn; Justin Sibert; Steven Pastor; Harold Riethman; Ming Xiao
Journal:  Genome Res       Date:  2017-10-12       Impact factor: 9.043

8.  Single-molecule analysis of subtelomeres and telomeres in Alternative Lengthening of Telomeres (ALT) cells.

Authors:  Heba Z Abid; Jennifer McCaffrey; Kaitlin Raseley; Eleanor Young; Katy Lassahn; Dharma Varapula; Harold Riethman; Ming Xiao
Journal:  BMC Genomics       Date:  2020-07-15       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.